| Literature DB >> 29914400 |
Wubareg Seifu1, Walid Ali2, Beyene Meresa3.
Abstract
BACKGROUND: Retention in care and adherence to the treatment is very important for the success of the program while access for treatment is being scaled up. Without more precise data about the rate of loss to follow up as well the characteristics of those who disengage from the treatment appropriate interventions to increase ART adherence cannot be designed and implemented. Therefore the aim of this study was to determine incidence and predictors of loss to follow up among adult ART clients attending in Karamara Hospital, Jigjiga town, Eastern Ethiopia, 2015.Entities:
Keywords: ART; Eastern Ethiopia; Jigjiga town; Loss to follow up; Predictors
Mesh:
Substances:
Year: 2018 PMID: 29914400 PMCID: PMC6006768 DOI: 10.1186/s12879-018-3188-4
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Fig. 1Profiles of HIV/AIDS clients at Karamara Hospital, Jigjiga (September 1, 2007 to September 1, 2014, Ethiopian Somali Regional State, Eastern Ethiopia; 2015
Baseline socio-demographic characteristics of adult ART patients at Karamara Hospital from September 1, 2007 to September 1, 2014), Somali region, Jigjiga town, Eastern Ethiopia, 2015
| Variables | Frequency | Percentage (%) |
|---|---|---|
| Sex | ||
| Male | 605 | 42.0 |
| Female | 834 | 58.0 |
| Religion | ||
| Muslim | 658 | 45.7 |
| Orthodox | 713 | 49.5 |
| Protestant | 60 | 4.2 |
| Others | 8 | 0.6 |
| Marital status | ||
| Married | 680 | 47.3 |
| Never married | 211 | 14.7 |
| Divorced | 391 | 27.2 |
| Widowed | 142 | 9.9 |
| Separated | 15 | 1.0 |
| Age group | ||
| 18–22 | 122 | 8.5 |
| 23–27 | 275 | 19.1 |
| 28–32 | 377 | 26.2 |
| 33–37 | 237 | 16.5 |
| 38–42 | 204 | 14.2 |
| > = 43 | 224 | 15.6 |
| Place of Residence | ||
| Jigjiga | 1258 | 87.4 |
| Out of Jigjiga | 181 | 12.6 |
| Educational status | ||
| No education | 487 | 33.8 |
| Primary level | 552 | 38.5 |
| Secondary and above | 388 | 27.0 |
| Employment status | ||
| Government | 205 | 14.2 |
| House wife | 116 | 8.1 |
| Daily laborer | 407 | 28.3 |
| Unemployed | 579 | 40.2 |
| Others | 132 | 9.1 |
| Contact Person | ||
| Yes | 1081 | 75.1 |
| No | 358 | 24.9 |
Baseline clinical characteristics of adult ART patients at Karamara Hospital from September 1, 2007 to September, 2014, Somali region, Jigjiga town, Eastern Ethiopia, 2015
| Variables | Frequency | Percentage (%) |
|---|---|---|
| CD4 cell count/μl | ||
| <=200 | 935 | 65.0 |
| 201–250 | 195 | 13.6 |
| 251–300 | 196 | 13.6 |
| 301–350 | 113 | 7.9 |
| > 351 | 113 | 7.9 |
| WHO stage | ||
| Stage I | 328 | 22.8 |
| Stage II | 228 | 15.8 |
| Stage III | 670 | 46.6 |
| Stage IV | 213 | 14.8 |
| History of TB treatment | ||
| Yes | 367 | 25.5 |
| No | 1072 | 74.5 |
| Next appointment recorded | ||
| Yes | 1092 | 75.9 |
| No | 347 | 24.1 |
| Base line functional status | ||
| Functional | 811 | 56.4 |
| Ambulatory | 488 | 33.9 |
| Bed ridden | 140 | 9.7 |
| ART regimen substitutions | ||
| Yes | 172 | 12.0 |
| No | 1267 | 88.0 |
| Disclosure status | ||
| Family members | 546 | 36.9 |
| Spouse only | 453 | 30.6 |
| No one | 358 | 24.2 |
| Relative/friend | 122 | 8.1 |
Fig. 2Number of clients retained and loss to follow up from ART program by each year at Karamara General Hospital, from September 1, 2007 to September, 2014, Ethiopian Somali regional State, Eastern Ethiopia, 2015
Fig. 3Kaplan-Meier estimation of cumulative incidence of loss to follow up by sex among adult ART attendants at Karamara Hospital, Jigjiga, Ethiopia, 2015
Cox regression analysis of factors associated with LTFU among adult patients on ART therapy at Karamara General Hospital, September 2007 to September 2014, Somali region, Jigjiga town, Eastern Ethiopia, 2015
| Variables | Loss to Follow Up | AHR | ||
|---|---|---|---|---|
| Yes | No | (95% CI) | ||
| Sex | ||||
| Male | 107 (34.2) | 498 (65.8) | 2.1 (1.3–3.4) | 0.034* |
| Female | 106 (24.7) | 728 (75.3) | 1 | |
| Next appointment recorded properly | ||||
| Yes | 190 (17.4) | 902 (82.6) | 1 | 0.000* |
| No | 23 (6.6) | 324 (93.4) | 1.2 (1.12–1.36) | |
| History of TB treatment | ||||
| Yes | 71 (19.4) | 296 (80.6) | 1.2 (0.08–1.38) | |
| No | 142 (13.2) | 930 (86.8) | 1 | 0.561 |
| WHO Stagea | ||||
| I | 38 (11.6) | 290 (88.4) | 1 | |
| II | 29 (12.7) | 199 (87.3) | 0.4 (0.34–2.34) | 0.341 |
| III | 111 (16.6) | 559 (83.4) | 0.8 (0.40–1.17) | 0.123 |
| IV | 35 (16.4) | 178 (83.6) | 0.6 (0.28–1.43) | 0.112 |
| Functional statusb | ||||
| Functional | 81 (10.0) | 730 (90.0) | 1 | |
| Ambulatory | 96 (19.6) | 392 (80.4) | 0.73 (0.44–1.2) | 0.2213 |
| Bed ridden | 36 (25.7) | 104 (74.3) | 1.31 (0.86–1.9) | 0.2364 |
| CD4 Count | ||||
| = < 200 | 152 (16.3) | 783 (83.7) | 0.7 (0.5–1.0) | 0.117 |
| 201–250 | 21 (10.8) | 174 (89.2) | 0.6 (0.4–1.8) | 0.712 |
| 251–300 | 16 (8.2) | 180 (91.8) | 0.7 (0.6–1.0) | 0.371 |
| 301–350 | 10 (8.9) | 103 (91.1) | 0.9 (1.1–1.8) | 0.682 |
| > = 351 | 14 (12.4) | 99 (87.6) | 1 | |
| Disclosure status | ||||
| Disclosed to any one | 76 (7.0) | 1005 (93.0) | 1 | |
| Not disclosed to any one | 137 (38.3) | 221 (61.7) | 2.8 (2.22–5.23) | 0.034* |
Note
*statistically significant at p-value < 0.05
ais based on the clinical sign and symptom complex
bFunctional = able to perform usual work in or out of the house, harvest, go to school
Ambulatory = able to perform activities of daily living but not able to work or play
Bedridden = not able to perform activities of daily living